Company Filing History:
12 out of 587 
1 out of 402 
Years Active: 2020-2024
Title: Innovator Spotlight: Tarek Abdelnapy Ahmed
Introduction:
Tarek Abdelnapy Ahmed, a distinguished inventor hailing from Jeddah, Saudi Arabia, has made significant contributions to the field of pharmaceuticals with a total of 12 patents under his name. His groundbreaking work focuses on enhancing bioavailability and prolonging the duration of medications, notably in the treatment of erectile dysfunction.
Latest Patents:
One of Tarek Abdelnapy Ahmed's latest patents includes a buccal formulation of avanafil with enhanced bioavailability and prolonged duration. This innovative tablet formulation consists of key components such as polyvinylpyrrolidone K-90, hydroxypropyl methylcellulose, sodium deoxycholate, porous silicon dioxide, mannitol, and avanafil. The unique ratio of these elements in the tablet aims to optimize the efficacy of the medication for the treatment of erectile dysfunction.
Career Highlights:
Tarek Abdelnapy Ahmed has a rich professional background, having worked at esteemed institutions such as King Abdulaziz University and Virginia Commonwealth University. His expertise in pharmaceuticals and drug delivery systems has led to the development of novel formulations that improve the therapeutic outcomes for patients.
Collaborations:
Throughout his career, Tarek Abdelnapy Ahmed has collaborated with accomplished individuals in the field, including coworkers like Khalid Mohamed El-Say and Abdelsattar Mansour Omar. These collaborations have fostered a culture of innovation and knowledge sharing, resulting in groundbreaking advancements in pharmaceutical research.
Conclusion:
In conclusion, Tarek Abdelnapy Ahmed stands out as a visionary inventor whose dedication to enhancing drug delivery systems has paved the way for improved treatment options in the pharmaceutical industry. His patents reflect a commitment to innovation and excellence, making him a prominent figure in the realm of pharmaceutical inventions.